Daytrana

ADHD gene doesn't predict response to stimulant meds

New research has shown that a gene linked to attention-deficit/hyperactivity disorder doesn't predict how well a person will respond to medications used to treat the disorder.
(Forbes) UPDATED 06/24/2008
View Full Story

Daytrana patches recalled again

The company that manufactures the Daytrana patch is recalling some of the products because of problems with the liner.
(CNNMoney.com) UPDATED 06/09/2008
View Full Story

Researchers to test new treatments for ADHD

Two new research projects will test behavioral therapy and computer games that use biofeedback to determine if either treatment can improve the symptoms of attention-deficit/hyperactivity disorder.
(PsychCentral) UPDATED 06/09/2008
View Full Story

Doctors explain heart screening advice for ADHD patients

The American Heart Association clarified a recent recommendation about stimulant medications and heart screenings by explaining that it is not mandatory to obtain an electrocardiogram and treatment for ADHD should not be withheld because an ECG is not done.
(Medical News Today) UPDATED 05/26/2008
View Full Story

Do ADHD meds slow a child's growth?

A recent study of Daytrana suggests that the attention-deficit/hyperactivity disorder medication does not affect a child's height or weight.
(ADHDCentral.com) UPDATED 05/20/2008
View Full Story

Study: Daytrana safe for long-term use

A study to test the long-term safety of the Daytrana patch showed that the medication is effective for girls and boys for as long as 12 months.
(Psych Central) UPDATED 05/08/2008
View Full Story


Navigation

Member Picks
Chronic pain harms the brain
View Full Story
Three vitamin supplements reflux sufferers may need
View Full Story
Research your meds on the Treatments tab
View Full Story
Caffeine could spell trouble for diabetics
View Full Story